User menu

Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen.

Bibliographic reference Lonchay, Christophe ; Hanagiri, Takeshi ; Colau, Didier ; Thielemans, Kris ; van Baren, Nicolas ; et. al. Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen.. In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101 Suppl 2, p. 14631-8 (2004)
Permanent URL
  1. Marchand Marie, van Baren Nicolas, Weynants Patrick, Brichard Vincent, Dr�no Brigitte, Tessier Marie-H�l�ne, Rankin Elaine, Parmiani Giorgio, Arienti Flavio, Humblet Yves, Bourlond Andr�, Vanwijck Romain, Li�nard Danielle, Beauduin Marc, Dietrich Pierre-Yves, Russo Vincenzo, Kerger Joseph, Masucci Giuseppe, J�ger Elke, De Greve Jacques, Atzpodien Jens, Brasseur Francis, Coulie Pierre G., van der Bruggen Pierre, Boon Thierry, Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1, 10.1002/(sici)1097-0215(19990118)80:2<219::aid-ijc10>;2-s
  2. Thurner Beatrice, Haendle Ina, Röder Claudia, Dieckmann Detlef, Keikavoussi Petra, Jonuleit Helmut, Bender Armin, Maczek Christian, Schreiner Doris, von den Driesch Peter, Bröcker Eva B., Steinman Ralph M., Enk Alexander, Kämpgen Eckhart, Schuler Gerold, Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma, 10.1084/jem.190.11.1669
  3. Coulie P. G., Karanikas V., Colau D., Lurquin C., Landry C., Marchand M., Dorval T., Brichard V., Boon T., A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3, 10.1073/pnas.161260098
  4. Altman J. D., Moss P. A. H., Goulder P. J. R., Barouch D. H., McHeyzer-Williams M. G., Bell J. I., McMichael A. J., Davis M. M., Phenotypic Analysis of Antigen-Specific T Lymphocytes, 10.1126/science.274.5284.94
  5. Genevée Catherine, Diu Anita, Nierat Janine, Caignard Anne, Dietrich Pierre-Yves, Ferradini Laurent, Roman-Roman Sergio, Triebel Frédéaric, Hercend Thierry, An experimentally validated panel of subfamily-specific oligonucleotide primers (Vα1-w29/Vβ1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction, 10.1002/eji.1830220522
  6. Chaux Pascal, Vantomme Valérie, Coulie Pierre, Boon Thierry, van der Bruggen Pierre, Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer, 10.1002/(sici)1097-0215(19980812)77:4<538::aid-ijc11>;2-2
  7. Dutoit Valérie, Rubio-Godoy Verena, Pittet Mikäel J., Zippelius Alfred, Dietrich Pierre-Yves, Legal Frédérique Anne, Guillaume Philippe, Romero Pedro, Cerottini Jean-Charles, Houghten Richard A., Pinilla Clemencia, Valmori Danila, Degeneracy of Antigen Recognition as the Molecular Basis for the High Frequency of Naive A2/Melan-A Peptide Multimer+CD8+T Cells in Humans, 10.1084/jem.20020242
  8. Coulie Pierre G., Karanikas Vaios, Lurquin Christophe, Colau Didier, Connerotte Thierry, Hanagiri Takeshi, Van Pel Aline, Lucas Sophie, Godelaine Daniele, Lonchay Christophe, Marchand Marie, van Baren Nicolas, Boon Thierry, Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen, 10.1034/j.1600-065x.2002.18804.x
  9. Godelaine D., Carrasco J., Lucas S., Karanikas V., Schuler-Thurner B., Coulie P. G., Schuler G., Boon T., Van Pel A., Polyclonal CTL Responses Observed in Melanoma Patients Vaccinated with Dendritic Cells Pulsed with a MAGE-3.A1 Peptide, 10.4049/jimmunol.171.9.4893
  10. Karanikas V., Lurquin C., Colau D., van Baren N., De Smet C., Lethe B., Connerotte T., Corbiere V., Demoitie M.-A., Lienard D., Dreno B., Velu T., Boon T., Coulie P. G., Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus, 10.4049/jimmunol.171.9.4898
  11. Luiten R.M., Demotte N., Tine J., van der Bruggen P., A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules, 10.1034/j.1399-0039.2000.560110.x
  12. Valmori, Cancer Research, 60, 4499 (2000)
  13. Zippelius Alfred, Pittet Mikaël J., Batard Pascal, Rufer Nathalie, de Smedt Magda, Guillaume Philippe, Ellefsen Kim, Valmori Danila, Liénard Danielle, Plum Jean, MacDonald H. Robson, Speiser Daniel E., Cerottini Jean-Charles, Romero Pedro, Thymic Selection Generates a Large T Cell Pool Recognizing a Self-Peptide in Humans, 10.1084/jem.20011658
  14. Arstila T. P., A Direct Estimate of the Human T Cell Receptor Diversity, 10.1126/science.286.5441.958
  15. Trigueros César, Ramiro Almudena R., Carrasco Yolanda R., de Yebenes Virginia G., Albar Juan P., Toribio María L., Identification of a Late Stage of Small Noncycling pTα− Pre-T Cells as Immediate Precursors of T Cell Receptor α/β+ Thymocytes, 10.1084/jem.188.8.1401
  16. Kemir C., Diversity of Human T Cell Receptors, 10.1126/science.288.5469.1135a
  17. Westermann Jürgen, Pabst Reinhard, Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system?, 10.1016/0167-5699(90)90160-b